Venture Leaders Medtech 2024 kick-off their Boston roadshow

19.09.2024 15:30, Rita Longobardi

In November, the ten Venture Leaders Medtech 2024 will represent Switzerland and pitch their solutions in Boston, USA. During their weeklong roadshow, the entrepreneurs will meet with investors, experts, and industry leaders to strengthen their network and advance global growth. The founders met at the startup space to introduce themselves and their startups and showcased their innovations at an online pitch session.

During the event on September 18th, the Venture Leaders Medtech 2024 learned more about each other’s innovations, talked about their startup journeys thus far, and pitched virtually their Medtech ventures. Audience members then voted for the team captain and selected Greta Preatoni, Co-Founder and CEO of MYNERVA, for the honor. "This represents a fantastic opportunity, as the US is MYNERVA's target market. Venture Leaders Medtech will help us forge strategic partnerships and connect with investors," said Greta.

As members of the Swiss National Startup Team, the Venture Leaders share a defined objective: to establish themselves as leading global entities and to boost their worldwide growth endeavours. “Preparing for this roadshow for the 18th year is a tribute to the quality of innovation and the startups that have been part of this journey,” shared Stefan Steiner, co-managing director of Venturelab. “I can’t wait to join this new edition and support the team in its international expansion.”

Venture Leaders Medtech is organized by Venturelab and Swissnex Boston and New York and supported by EPFL, ETH Zürich, Hansjörg Wyss, Health Innovation Hub Aargau, Kellerhals Carrard, Canton de Vaud, Canton of Zurich, and Vischer.


From left to right (up-down): David Sachs (CITUS), Pablo Lara (OncoSwab), Anna Luisa Schaffgotsch (Implì), Michael Rottmann (One Twenty), Marie-Agnès Doucey (Calico Biosystems), André Jaun (Metadvice), Markus Windolf (BIOS Medical), Waldemar Hoffman (Apersys), Great Preatoni (MYNERVA),  and Eashan Saikia (Aseptuva)

Venturelab has 18 years of experience bringing Switzerland’s best entrepreneurs to the heart of the global technology hubs: Silicon
Valley, New York, Boston, Barcelona, London, Munich, Beijing, Shanghai, Shenzhen, and Hong Kong. Companies founded by the 560 Venture Leaders alumni have created more than 11,900 jobs and raised more than CHF 8,3 billion in capital. For more information, visit www.venture-leaders.ch, and discover all the alumni here.



Follow the entrepreneurs and the Venture Leaders Medtech roadshow from November 4th to November 8th, 2024, on social media using the hashtag #VLeadersMedtech or on www.venture-leaders.ch/Medtech.

Learn more about Venture Leaders Medtech 2024:

Apersys AG: Overcoming organ shortage.
Apersys is on a mission to save more patients in need of an organ transplant. Their perfusion platform technology paves the way for improving the number of transplantable organs and... Read more

BIOS Medical AG: Implanted BIOSensors to restore life.
BIOS Medical is pioneering a revolution in orthopaedic aftercare through implantable biosensors. It monitors progress remotely 24/7 to enable a personalized care pathway... Read more

Metadvice: Accelerating Personalised and Complex Disease Care
Metadvice AI distills complex disease treatment and outcome data into actionable insights for clinicians and patients, assisting pharmaceutical companies with real-world evidence... Read more

MYNERVA: Reducing Pain and falls through AI-driven neurostimulation
MYNERVA has developed Leia, a groundbreaking medical device able to reduce falls and chronic pain in patients suffering from diabetic neuropathy through a combination of Artificial Intelligence and Non-invasive neurostimulation... Read more